Bill Text: IL HB0240 | 2017-2018 | 100th General Assembly | Introduced


Bill Title: Amends the Third Party Prescription Programs Article of the Insurance Code, the Pharmacy Practice Act of 1987, and the Wholesale Drug Distribution Licensing Act. Prohibits the licensure, transference, use, or sale of any records relative to prescription information containing patient-identifiable or prescriber-identifiable data by any licensee or registrant of the Acts for commercial purposes.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Failed) 2019-01-08 - Session Sine Die [HB0240 Detail]

Download: Illinois-2017-HB0240-Introduced.html


100TH GENERAL ASSEMBLY
State of Illinois
2017 and 2018
HB0240

Introduced , by Rep. Mary E. Flowers

SYNOPSIS AS INTRODUCED:
215 ILCS 5/512-4.5 new
225 ILCS 85/15.7 new
225 ILCS 120/53 new

Amends the Third Party Prescription Programs Article of the Insurance Code, the Pharmacy Practice Act of 1987, and the Wholesale Drug Distribution Licensing Act. Prohibits the licensure, transference, use, or sale of any records relative to prescription information containing patient-identifiable or prescriber-identifiable data by any licensee or registrant of the Acts for commercial purposes.
LRB100 00016 SMS 10017 b
FISCAL NOTE ACT MAY APPLY

A BILL FOR

HB0240LRB100 00016 SMS 10017 b
1 AN ACT concerning regulation, which may be known as the
2Prescription Data Privacy Act.
3 Be it enacted by the People of the State of Illinois,
4represented in the General Assembly:
5 Section 5. The Illinois Insurance Code is amended by adding
6Section 512-4.5 as follows:
7 (215 ILCS 5/512-4.5 new)
8 Sec. 512-4.5. License, transfer, use, and sale of
9prescription information prohibited.
10 (a) In this Section, "commercial purpose" includes,
11without limitation, advertising, marketing, promotion, or any
12activity that could be used to (i) influence sales or market
13share of a pharmaceutical product, (ii) influence or evaluate
14the prescribing behavior of an individual health care
15professional, or (iii) evaluate the effectiveness of a
16professional pharmaceutical sales force.
17 (b) Records relative to prescription information
18containing patient-identifiable or prescriber-identifiable
19data may not be licensed, transferred, used, or sold by any
20registrant under this Act for any commercial purpose, except
21for any of the following limited purposes:
22 (1) Pharmacy reimbursement.
23 (2) Formulary compliance.

HB0240- 2 -LRB100 00016 SMS 10017 b
1 (3) Care management.
2 (4) Utilization review by a health care provider, the
3 patient's insurance provider, or the agent of either.
4 (5) Health care research.
5 (6) Any purpose otherwise provided by law.
6 (c) Nothing in this Section shall prohibit the dispensing
7of prescription medications to a patient or to the patient's
8authorized representative; the transmission of prescription
9information between an authorized prescriber and a licensed
10pharmacy; the transfer of prescription information between
11licensed pharmacies; the transfer of prescription records that
12may occur in the event a pharmacy ownership is changed or
13transferred; or care management educational communications
14provided to a patient about the patient's health condition,
15adherence to a prescribed course of therapy, or other
16information about the drug being dispensed, treatment options,
17or clinical trials.
18 (d) Nothing in this Section shall prohibit the collection,
19use, transfer, or sale of patient and prescriber de-identified
20data by zip code, geographic region, or medical specialty for
21commercial purposes.
22 Section 10. The Pharmacy Practice Act of 1987 is amended by
23adding Section 15.7 as follows:
24 (225 ILCS 85/15.7 new)

HB0240- 3 -LRB100 00016 SMS 10017 b
1 Sec. 15.7. License, transfer, use, and sale of prescription
2information prohibited.
3 (a) In this Section, "commercial purpose" includes,
4without limitation, advertising, marketing, promotion, or any
5activity that could be used to (i) influence sales or market
6share of a pharmaceutical product, (ii) influence or evaluate
7the prescribing behavior of an individual health care
8professional, or (iii) evaluate the effectiveness of a
9professional pharmaceutical sales force.
10 (b) Records relative to prescription information
11containing patient-identifiable or prescriber-identifiable
12data may not be licensed, transferred, used, or sold by any
13licensee or registrant under this Act for any commercial
14purpose, except for any of the following limited purposes:
15 (1) Pharmacy reimbursement.
16 (2) Formulary compliance.
17 (3) Care management.
18 (4) Utilization review by a health care provider, the
19 patient's insurance provider, or the agent of either.
20 (5) Health care research.
21 (6) Any purpose otherwise provided by law.
22 (c) Nothing in this Section shall prohibit the dispensing
23of prescription medications to a patient or to the patient's
24authorized representative; the transmission of prescription
25information between an authorized prescriber and a licensed
26pharmacy; the transfer of prescription information between

HB0240- 4 -LRB100 00016 SMS 10017 b
1licensed pharmacies; the transfer of prescription records that
2may occur in the event a pharmacy ownership is changed or
3transferred; or care management educational communications
4provided to a patient about the patient's health condition,
5adherence to a prescribed course of therapy, or other
6information about the drug being dispensed, treatment options,
7or clinical trials.
8 (d) Nothing in this Section shall prohibit the collection,
9use, transfer, or sale of patient and prescriber de-identified
10data by zip code, geographic region, or medical specialty for
11commercial purposes.
12 Section 15. The Wholesale Drug Distribution Licensing Act
13is amended by adding Section 53 as follows:
14 (225 ILCS 120/53 new)
15 Sec. 53. License, transfer, use, and sale of prescription
16information prohibited.
17 (a) In this Section, "commercial purpose" includes,
18without limitation, advertising, marketing, promotion, or any
19activity that could be used to (i) influence sales or market
20share of a pharmaceutical product, (ii) influence or evaluate
21the prescribing behavior of an individual health care
22professional, or (iii) evaluate the effectiveness of a
23professional pharmaceutical sales force.
24 (b) Records relative to prescription information

HB0240- 5 -LRB100 00016 SMS 10017 b
1containing patient-identifiable or prescriber-identifiable
2data may not be licensed, transferred, used, or sold by any
3licensee under this Act for any commercial purpose, except for
4any of the following limited purposes:
5 (1) Pharmacy reimbursement.
6 (2) Formulary compliance.
7 (3) Care management.
8 (4) Utilization review by a health care provider, the
9 patient's insurance provider, or the agent of either.
10 (5) Health care research.
11 (6) Any purpose otherwise provided by law.
12 (c) Nothing in this Section shall prohibit the dispensing
13of prescription medications to a patient or to the patient's
14authorized representative; the transmission of prescription
15information between an authorized prescriber and a licensed
16pharmacy; the transfer of prescription information between
17licensed pharmacies; the transfer of prescription records that
18may occur in the event a pharmacy ownership is changed or
19transferred; or care management educational communications
20provided to a patient about the patient's health condition,
21adherence to a prescribed course of therapy, or other
22information about the drug being dispensed, treatment options,
23or clinical trials.
24 (d) Nothing in this Section shall prohibit the collection,
25use, transfer, or sale of patient and prescriber de-identified
26data by zip code, geographic region, or medical specialty for

HB0240- 6 -LRB100 00016 SMS 10017 b
1commercial purposes.
feedback